Table 2.
Correlation of arterial stiffness measurement and high-sensitive C-reactive protein
| Variable | Overall (n = 258) | Males (n = 153) | Females (n = 105) |
|---|---|---|---|
|
Office BP (mmHg) | |||
| SBP |
0.048 |
0.038 |
0.054 |
| DBP |
0.040 |
0.045 |
0.031 |
| Pulse pressure |
0.026 |
−0.004 |
0.060 |
| Heart rate |
0.186** |
0.206* |
0.189 |
|
ABPM 24 hours (mmHg) | |||
| SBP |
0.126* |
0.196* |
0.023 |
| DBP |
0.055 |
0.161* |
−0.125 |
| Pulse pressure |
0.115 |
0.100 |
0.145 |
| Heart rate |
0.246** |
0.306** |
0.144 |
|
Home BP (mmHg) | |||
| SBP |
0.185** |
0.212** |
0.138 |
| DBP |
0.137* |
0.188* |
0.047 |
| PP |
0.134* |
0.123 |
0.142 |
| Heart rate |
0.189** |
0.200* |
0.196 |
| Total cholesterol (mg/dL) |
−0.004 |
0.044 |
−0.060 |
| LDL-cholesterol (mg/dL) |
0.063 |
0.094 |
0.031 |
| HDL-cholesterol (mg/dL) |
−0.198** |
−0.138 |
−0.282** |
| No HDL-cholesterol (mg/dL) |
0.063 |
0.083 |
0.034 |
| Atherogenic Index |
0.171** |
0.141 |
0.211* |
| Ln Cardiovascular risk DAgostino |
0.188** |
0.238** |
0.086 |
| Waist circumference (cm) |
0.235** |
0.215** |
0.275** |
| Maximum IMT (mm) |
0.194** |
0.290** |
0.011 |
| Mean IMT (mm) |
0.174** |
0.261** |
0.010 |
| PWV (m/sec) |
0.280** |
0.250** |
0.319** |
| CAIx |
−0.048 |
0.067 |
−0.222* |
| PAIx |
0.068 |
0.166* |
−0.058 |
| AASI |
0.067 |
−0.027 |
0.215* |
| AASI-BPVR |
−0.012 |
0.012 |
−0.049 |
| Awake-AASI |
0.057 |
−0.034 |
0.198 |
| Sleep-AASI |
0.093 |
0.005 |
0.240* |
| HASI |
−0.013 |
−0.044 |
0.057 |
| HASI-BPVR | −0.049 | −0.059 | 0.004 |
BP: blood pressure; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; AMBP: Ambulatory blood pressure monitoring; HDL, high density lipoprotein; LDL, low density lipoprotein; IMT: Intima Media Thickness; PWV: pulse wave velocity; CAIx: Central augmentation index; PAIx: Peripheral augmentation index, AASI: Ambulatory arterial stiffness index, BPVR: Blood pressure variability ratio; HASI: Home arterial stiffness index.